SUNNYVALE, Calif.—Amy Ladd, a director at Intuitive Surgical Inc . (NASDAQ:ISRG), a medical technology company with a market capitalization of $204.6 billion, recently sold 150 shares of the company's common stock, according to a filing with the Securities and Exchange Commission. The shares were sold at a price of $566.6 each, amounting to a total transaction value of $84,990. Following this transaction, Ladd holds 671 shares in the company. The sale was executed as part of a pre-established trading plan in compliance with SEC Rule 10b5-1, which is set to expire on July 25, 2025. The stock, which has delivered a remarkable 51% return over the past year, is currently trading near its 52-week high. According to InvestingPro analysis, the stock appears to be trading above its Fair Value, with 16+ additional insights available to subscribers through comprehensive Pro Research Reports.
In other recent news, Intuitive Surgical has been the center of attention for several analysts following its impressive fourth-quarter earnings report. RBC Capital Markets maintained a positive outlook on the company, reaffirming an Outperform rating and a price target of $641.00. The firm highlighted the company's strong performance in the fourth quarter of 2024, surpassing expectations with a 10% and 24% beat on revenue and earnings per share (EPS), respectively.
Piper Sandler increased the price target on Intuitive Surgical shares to $670, maintaining an Overweight rating. Bernstein analysts reaffirmed an Outperform rating for Intuitive Surgical, setting a price target of $700, based on the company's strong financial performance in the last quarter and the company's growth prospects supported by five transformational product cycles. Truist Securities updated its outlook on Intuitive Surgical, increasing the price target to $666, while maintaining a Buy rating.
These recent developments reflect a range of perspectives among analysts, with some expressing optimism about the company's future growth prospects, and others expressing a more cautious outlook due to external pressures and uncertainties. These are the recent developments in the company's journey.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.